[1] |
FANG Zhie, LI Chengxian, BAI Zhaofang, ZHAO Xu, WANG Jiabo, XIAO Xiaohe.
Investigation of objectivity in the relationship between aristolochic acid and hepatocellular carcinoma
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 20-24.
|
[2] |
DING Qian, LI Boyu, ZHANG Qingxia.
Risks to storage of nitroglycerin after unsealing and ways of prevention
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 326-330.
|
[3] |
LI Meng, LI Rongrong, LIU Chenghai.
Clinic diagnosis and treatment of herb-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 127-131.
|
[4] |
ZHOU Lirun, CUI Xiaolan, SHI Yujing.
Research progress in drugs for respiratory virus and anti-respiratory virus
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 225-230.
|
[5] |
CHU Yanqi, JIANG Yongxian, SHEN Jianghua, XING Xiaoxuan, ZHANG Qingxia, YAN Suying.
Analgesia-related risks after thoracoscopic surgery in elderly patients
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1023-1026.
|
[6] |
ZHANG Qingxia, JIANG Yongxian, LI Gen, YAN Suying, WANG Yuqin.
Analysis and prevention of medication errors related to stored pharmaceuticals in National Monitoring Network for Clinical Safety Medication
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1040-1044.
|
[7] |
ZHANG Qingxia, JIANG Yongxian, DONG Yuexin, XIAN Ying, YAN Suying.
Risk analysis and precautions related to storage conditions specified in package inserts of western medicines in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 913-918.
|
[8] |
SHAO Chen, ZHANG Qingxia, YAN Suying, WANG Yuqin.
Analysis of 1028 statins-related medication errors and prevention strategies
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 645-648.
|
[9] |
ZHAO Xuan, GUO Jing, MEI Long, ZHANG Wei.
Automatic dispensing system on influence of work efficiency of outpatient pharmacy and the safety of prevention and control of COVID-19
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 564-567.
|
[10] |
ZHANG Qingxia, DING Qian, YAN Suying, WANG Yuqin.
Analysis and prevention of medication errors of dabigatran etexilate and rivaroxaban
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(12): 1372-1375.
|
[11] |
ZHANG Qingxia, JIANG Yongxian, DONG Yuexin, XIAN Ying, WANG Yuqin, YAN Suying.
Risk investigation of insulin storage and analysis and prevention of typical insulin-related medication errors
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1242-1245.
|
[12] |
ZHAO Xuan, GUO Jing, REN Shuang, ZHEN Jiancun.
Management and working modes of outpatient pharmacies amid routine COVID-19 epidemic prevention
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 100-102.
|
[13] |
GAO Yunjuan, ZHAO Xu, BAI Zhaofang, WANG Jiabo, ZHAN Xiaoyan, GUO Yuming, XIAO Xiaohe.
Prevention and Control of Safety Risks of Traditional Chinese Medicine Based on Indirect Knowledge of Toxicity
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1004-1008.
|
[14] |
SONG Yingjie, WANG Haiyan, LI Yujia.
Prevention of Harmful Drug Reactions in Pharmacovigilance System
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(1): 52-55.
|
[15] |
XUE Jing, GAO Min, PAN Ying, LI Xiaoyan.
Clinical Analysis and Countermeasures of Oxaliplatin-induced Allergic in Our Hospital
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(6): 361-365.
|